Oral oestrogen reverses ovariectomy-induced morning surge hypertension in growth-restricted mice

Clinical Science
Sarah E HaskellRobert D Roghair

Abstract

Perinatal growth restriction (GR) is associated with heightened sympathetic tone and hypertension. We have previously shown that naturally occurring neonatal GR programmes hypertension in male but not female mice. We therefore hypothesized that intact ovarian function or post-ovariectomy (OVX) oestrogen administration protects GR female mice from hypertension. Utilizing a non-interventional model that categorizes mice with weanling weights below the tenth percentile as GR, control and GR adult mice were studied at three distinct time points: baseline, post-OVX and post-OVX with oral oestrogen replacement. OVX elicited hypertension in GR mice that was significantly exacerbated by psychomotor arousal (systolic blood pressure at light to dark transition: control 122 ± 2; GR 119 ± 2; control-OVX 116 ± 3; GR-OVX 126 ± 3 mmHg). Oestrogen partially normalized the rising blood pressure surge seen in GR-OVX mice (23 ± 7% reduction). GR mice had left ventricular hypertrophy, and GR-OVX mice in particular had exaggerated bradycardic responses to sympathetic blockade. For GR mice, a baseline increase in baroreceptor reflex sensitivity and high frequency spectral power support a vagal compensatory mechanism, and that compensation was lost f...Continue Reading

References

Sep 9, 1989·Lancet·D J BarkerS J Simmonds
Sep 19, 1997·Early Human Development·J L CresswellD J Barker
Jan 26, 2000·Menopause : the Journal of the North American Menopause Society·B SzekacsE A Brinton
Feb 28, 2002·American Journal of Hypertension·Andrew SherwoodAlan L Hinderliter
May 10, 2002·The American Journal of Cardiology·G MercuroG M Rosano
Sep 27, 2003·Seminars in Perinatology·Anna M DusickJames A Lemons
Dec 2, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Gilles CambonieAnne Monique Nuyt
Oct 6, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kazuo EguchiKazuomi Kario
Jan 16, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Robert D RoghairFred S Lamb
Jun 19, 2009·The Canadian Journal of Cardiology·Faye S RoutledgeC R Dean
Jan 1, 2008·Journal of the American Society of Hypertension : JASH·William B WhiteVijay Chauhan
Dec 6, 2011·General and Comparative Endocrinology·E IngbergJ O Strom
May 10, 2012·Journal of Nutrition and Metabolism·Gary J KummetRobert D Roghair
Dec 13, 2012·Pediatric Research·Sarah E HaskellRobert D Roghair
Feb 23, 2013·Frontiers in Physiology·George E Billman
Jun 7, 2013·American Journal of Physiology. Renal Physiology·Barbara T Alexander, Suttira Intapad
Jul 9, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Yoshiyuki OkadaQi Fu
Dec 17, 2014·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Jun-Chao XieXue-Yuan Liu

❮ Previous
Next ❯

Citations

Sep 11, 2016·The Journal of Endocrinology·Baiba Steinbrekera, Robert Roghair
May 8, 2018·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Madeline H KnottRobert D Roghair
Oct 20, 2017·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Baojian XueAlan Kim Johnson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.